Patents by Inventor Naohiko Anzai

Naohiko Anzai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • URAT1 inhibitor
    Patent number: 10173990
    Abstract: Provided are a compound represented by the following Formula (III), a tautomer or stereoisomer of the compound, or a pharmaceutically acceptable salt or solvate thereof used as a therapeutic agent for gout or hyperuricemia.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: January 8, 2019
    Assignees: Nippon Chemiphar Co., Ltd., J-Pharma Co., Ltd., DeThree Res. Lab. Inc.
    Inventors: Tsuyoshi Endo, Kunio Kobayashi, Hiroto Tanaka, Daisuke Saito, Masuharu Hirano, Hitoshi Endou, Naohiko Anzai
  • Anticancer agent composition
    Patent number: 10172835
    Abstract: A method for treating cancer includes administering to a subject in need of the treatment an anticancer agent composition that includes the following agents as active ingredients; a LAT1 inhibitor, and one or more agents selected from the group consisting of an alkylating agent, a platinum-based antineoplastic agent, an anti-metabolite, a topoisomerase inhibitor, an anti-microtubule polymerizing agent, a hormonal agent, an anti-microtubule depolymerizing agent, an anticancer antibiotic, and a molecular targeted agent.
    Type: Grant
    Filed: June 7, 2014
    Date of Patent: January 8, 2019
    Assignee: J-Pharma Co., Ltd.
    Inventors: Hitoshi Endou, Michael F. Wempe, Jean-Francois Peyron, Naohiko Anzai, Promsuk Jutabha
  • URAT1 INHIBITOR
    Publication number: 20170290795
    Abstract: Provided are a compound represented by the following Formula (III), a tautomer or stereoisomer of the compound, or a pharmaceutically acceptable salt or solvate thereof used as a therapeutic agent for gout or hyperuricemia.
    Type: Application
    Filed: December 28, 2015
    Publication date: October 12, 2017
    Applicant: J-Pharma Co., Ltd.
    Inventors: Tsuyoshi Endo, Kunio Kobayashi, Hiroto Tanaka, Daisuke Saito, Masaharu Hirano, Hitoshi Endou, Naohiko Anzai
  • AN ANTICANCER AGENT COMPOSITION
    Publication number: 20160279103
    Abstract: A method for treating cancer includes administering to a subject in need of the treatment an anticancer agent composition that includes the following agents as active ingredients; a LAT1 inhibitor, and one or more agents selected from the group consisting of an alkylating agent, a platinum-based antineoplastic agent, an anti-metabolite, a topoisomerase inhibitor, an anti-microtubule polymerizing agent, a hormonal agent, an anti-microtubule depolymerizing agent, an anticancer antibiotic, and a molecular targeted agent.
    Type: Application
    Filed: June 7, 2014
    Publication date: September 29, 2016
    Applicant: J-Pharma Co., Ltd.
    Inventors: Hitoshi Endou, Michael F. Wempe, Jean-Francois Peyron, Naohiko Anzai, Promsuk Jutabha